Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ID 110521156

Next Previous
Drug Profile

ID 110521156

Alternative Names: ID-11052; ID-110521156

Latest Information Update: 14 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ildong Pharmaceutical
  • Class Antihyperglycaemics; Obesity therapies; Small molecules
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 20 Jun 2025 Adverse events and pharmacokinetics data from a phase I SAD trial (In volunteers) presented at the 85th Annual Scientific Sessions of the American Diabetes Association (ADA-2025)
  • 13 Nov 2024 IlDong Pharmaceutical initiates phase I trial in volunteers in South Korea (PO, Capsule) (NCT06635226)
  • 10 Oct 2024 IlDong Pharmaceuticals plans a phase I trial (In volunteers) in Suth korea (PO, Capsule) in October 2024 (NCT06635226)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top